2019
DOI: 10.1038/s41598-019-46112-z
|View full text |Cite
|
Sign up to set email alerts
|

In vitro characterization of sonothrombolysis and echocontrast agents to treat ischemic stroke

Abstract: The development of adjuvant techniques to improve thrombolytic efficacy is important for advancing ischemic stroke therapy. We characterized octafluoropropane and recombinant tissue plasminogen activator (rt-PA)-loaded echogenic liposomes (OFP t-ELIP) using differential interference and fluorescence microscopy, attenuation spectroscopy, and electrozone sensing. The loading of rt-PA in OFP t-ELIP was assessed using spectrophotometry. Further, it was tested whether the agent shields rt-PA against degradation by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
22
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 25 publications
(23 citation statements)
references
References 95 publications
1
22
0
Order By: Relevance
“…24,53,58 Recently, Shekhar et al evaluated the nature of the echogenic behaviors of liposomes using differential interference contrast microcopy (DIC). 62 Their DIC images showed micrometer sized bubbles encapsulated inside liposome, but the typical size of the observable liposomes in the DIC images were far larger; the number weighted and volumeweighted diameters of these vesicles were 1.35 mm and 8.23 mm respectively. 62 The exosomes studied here, unlike previously studied echogenic liposomes and the polymersomes, are preformed vesicles, but they underwent the same freeze-drying procedure in presence of mannitol that was also part of the preparation protocol for echogenic liposomes and polymersomes.…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…24,53,58 Recently, Shekhar et al evaluated the nature of the echogenic behaviors of liposomes using differential interference contrast microcopy (DIC). 62 Their DIC images showed micrometer sized bubbles encapsulated inside liposome, but the typical size of the observable liposomes in the DIC images were far larger; the number weighted and volumeweighted diameters of these vesicles were 1.35 mm and 8.23 mm respectively. 62 The exosomes studied here, unlike previously studied echogenic liposomes and the polymersomes, are preformed vesicles, but they underwent the same freeze-drying procedure in presence of mannitol that was also part of the preparation protocol for echogenic liposomes and polymersomes.…”
Section: Discussionmentioning
confidence: 98%
“…62 Their DIC images showed micrometer sized bubbles encapsulated inside liposome, but the typical size of the observable liposomes in the DIC images were far larger; the number weighted and volumeweighted diameters of these vesicles were 1.35 mm and 8.23 mm respectively. 62 The exosomes studied here, unlike previously studied echogenic liposomes and the polymersomes, are preformed vesicles, but they underwent the same freeze-drying procedure in presence of mannitol that was also part of the preparation protocol for echogenic liposomes and polymersomes. 18,24,28,53,58,[63][64][65] However, unlike echogenic liposomes carrying encapsulated microbubble inside studied by Shekhar et al 62 the echogenic exosomes are much smaller in size-50-150 nm.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…NO-OFP-MB, Nitric oxide and octafluoropropane microbubbles. Definity ® as previously reported (Shekhar et al, 2019a). A previous study employed the Griess assay in combination with serial dialysis for NO dose assessment within liposomes (Huang et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Drug loaded microbubbles are of interest due to their potential to minimize non-site specific tPA or urokinase binding. Because the thrombolytic drug is primarily released when activated by ultrasound, and the ultrasound is only focused on the clot of interest, this may both minimize hemorrhage risks while also taking advantage of the synergistic improvements of thrombolysis outcomes with MBs and thrombolytic agents [87][88][89][90][91][92]. Both urokinase loaded echogenic liposomes and tPA loaded echogenic liposomes outperform using a thrombolytic agent alone or thrombolytic agent mediated sonothrombolysis.…”
Section: Novel Contrast Agents For Sonothrombolysismentioning
confidence: 99%